Boston Trust Walden’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.81M Sell
23,101
-254
-1% -$20.5K 0.01% 262
2026
Q1
$2.02M Buy
23,355
+1,779
+8% +$170K 0.02% 261
2025
Q4
$2.07M Sell
21,576
-30,478
-59% -$2.96M 0.02% 254
2025
Q3
$4.96M Sell
52,054
-85,690
-62% -$7.88M 0.04% 223
2025
Q2
$12M Sell
137,744
-3,645
-3% -$309K 0.09% 198
2025
Q1
$12.7M Buy
141,389
+8,047
+6% +$720K 0.09% 194
2024
Q4
$10.7M Sell
133,342
-3,872
-3% -$335K 0.07% 203
2024
Q3
$12.4M Sell
137,214
-1,446
-1% -$122K 0.09% 193
2024
Q2
$10.9M Sell
138,660
-3,705
-3% -$304K 0.08% 195
2024
Q1
$12.4M Sell
142,365
-15,475
-10% -$1.32M 0.09% 186
2023
Q4
$13M Sell
157,840
-68,592
-30% -$5.23M 0.1% 181
2023
Q3
$17.7M Sell
226,432
-11,230
-5% -$940K 0.15% 171
2023
Q2
$20.9M Sell
237,662
-6,868
-3% -$591K 0.17% 164
2023
Q1
$19.7M Sell
244,530
-35,243
-13% -$2.87M 0.17% 171
2022
Q4
$21.7M Buy
279,773
+22,696
+9% +$1.84M 0.19% 166
2022
Q3
$20.8M Sell
257,077
-362,740
-59% -$32.6M 0.21% 164
2022
Q2
$55.6M Buy
619,817
+1,906
+0.3% +$193K 0.53% 62
2022
Q1
$68.6M Buy
617,911
+20,377
+3% +$2.15M 0.57% 54
2021
Q4
$61.8M Buy
597,534
+19,645
+3% +$2.27M 0.5% 61
2021
Q3
$72.4M Sell
577,889
-4,634
-0.8% -$600K 0.64% 39
2021
Q2
$72.3M Buy
582,523
+22,226
+4% +$2.79M 0.64% 40
2021
Q1
$66.2M Sell
560,297
-43,637
-7% -$5.11M 0.64% 43
2020
Q4
$70.7M Buy
603,934
+7,788
+1% +$857K 0.75% 30
2020
Q3
$62M Buy
596,146
+7,403
+1% +$743K 0.77% 29
2020
Q2
$54M Buy
588,743
+24,140
+4% +$2.31M 0.73% 31
2020
Q1
$50.9M Buy
564,603
+49,444
+10% +$5.26M 0.81% 30
2019
Q4
$58.4M Buy
515,159
+6,855
+1% +$752K 0.68% 36
2019
Q3
$55.2M Buy
508,304
+49,804
+11% +$5.2M 0.69% 36
2019
Q2
$44.7M Buy
458,500
+6,348
+1% +$580K 0.58% 46
2019
Q1
$41.2M Buy
452,152
+10,958
+2% +$981K 0.56% 50
2018
Q4
$40.1M Sell
441,194
-2,745
-0.6% -$257K 0.64% 42
2018
Q3
$43.7M Sell
443,939
-4,515
-1% -$417K 0.6% 49
2018
Q2
$38.4M Sell
448,454
-6,970
-2% -$582K 0.56% 51
2018
Q1
$36.5M Sell
455,424
-29,655
-6% -$2.45M 0.55% 54
2017
Q4
$39.2M Sell
485,079
-28,467
-6% -$2.28M 0.57% 49
2017
Q3
$39.9M Buy
513,546
+10,461
+2% +$869K 0.62% 48
2017
Q2
$44.6M Buy
503,085
+9,248
+2% +$780K 0.72% 38
2017
Q1
$39.8M Buy
493,837
+4,476
+0.9% +$350K 0.62% 45
2016
Q4
$34.9M Sell
489,361
-69,257
-12% -$5.44M 0.55% 56
2016
Q3
$48.3M Buy
558,618
+10,143
+2% +$884K 0.8% 33
2016
Q2
$47.6M Sell
548,475
-2,468
-0.4% -$200K 0.81% 31
2016
Q1
$41.3M Buy
+550,943
New +$41.5M 0.72% 34
2015
Q4
Sell
-570,232
Closed -$38.2M 353
2015
Q3
$38.2M Sell
570,232
-3,845
-0.7% -$283K 0.64% 43
2015
Q2
$42.5M Sell
574,077
-23,556
-4% -$1.8M 0.65% 40
2015
Q1
$46.6M Buy
597,633
+45,814
+8% +$3.47M 0.69% 39
2014
Q4
$39.8M Buy
551,819
+40,535
+8% +$2.82M 0.59% 60
2014
Q3
$31.7M Sell
511,284
-11,547
-2% -$734K 0.49% 82
2014
Q2
$33.3M Sell
522,831
-10,865
-2% -$660K 0.48% 95
2014
Q1
$32.8M Sell
533,696
-1,929
-0.4% -$112K 0.49% 95
2013
Q4
$30.7M Sell
535,625
-6,540
-1% -$371K 0.45% 98
2013
Q3
$28.9M Sell
542,165
-5,330
-1% -$287K 0.44% 107
2013
Q2
$28.2M Buy
+547,495
New +$27.1M 0.46% 105

Other funds holding MDT

Boston Trust Walden's MDT Position: Q2 2026 in Review

Boston Trust Walden reduced its Medtronic (MDT) stake by 1.1% in Q2 2026, selling an estimated $20.5K and leaving 23,101 shares worth $1.81M. The position accounts for 0.01% of the portfolio, ranked #262.

Boston Trust Walden first reported a position in MDT in Q2 2013 and has held it in 52 quarters since. The position peaked at $72.4M in Q3 2021. 901 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Boston Trust Walden held 23,101 shares of Medtronic worth $1.81M as of Q2 2026.
  • Boston Trust Walden sold 254 Medtronic shares in Q2 2026, an estimated $20.5K.
  • Medtronic made up 0.01% of Boston Trust Walden's portfolio in Q2 2026, its #262 holding.
  • Boston Trust Walden first reported a position in Medtronic in Q2 2013 and has held it in 52 quarters since.
  • Boston Trust Walden's Medtronic position peaked at $72.4M in Q3 2021.
  • 901 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Boston Trust Walden's 13F filing for Q2 2026, filed 24 Jul 2026.